Artificial Intelligence Solution Expands Access to Care
Digital Diagnostics, an artificial intelligence diagnostic health care company, has expanded into lab settings in the Southeastern U.S.
Read MorePosted by Chris Wolski | Apr 21, 2023 | Diabetes & Metabolic Diseases, Lab Automation |
Digital Diagnostics, an artificial intelligence diagnostic health care company, has expanded into lab settings in the Southeastern U.S.
Read MorePosted by Chris Wolski | Apr 19, 2023 | Diabetes & Metabolic Diseases, POC Instruments |
Orange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read MorePosted by Andy Lundin | Apr 13, 2023 | Disease States |
The sensor was fabricated using a 3D printer and was capable of early diagnosis, also serving as a model for identifying other diseases.
Read MorePosted by Andy Lundin | Apr 4, 2023 | Cardiovascular, Kidney Disease |
A new proteomic risk model for cardiovascular disease was found to be more accurate than current methods of measuring cardiac risk
Read MorePosted by Andy Lundin | Apr 4, 2023 | Diabetes & Metabolic Diseases |
The new panels are designed to target dozens of microbially-derived metabolites across multiple pathways to advance pre-clinical efforts.
Read More